Biotechnology Stock in Focus; Neuralstem Inc. (CUR)
News | 14 September 2012
Shares of Neuralstem Inc. (AMEX: CUR) surged in trading on Thursday after the biotechnology company announced that its neural stem cells were part of a study published online in a leading scientific journal CELL. In the study, called Long Distance ...
Click on the link to read the full article at SmallCap Network
(This link will open in a new window)
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
